HLS Therapeutics Inc (DE:74D)

HLS Therapeutics Inc (74D) Balance Sheet


HLS Therapeutics Inc Balance Sheet

HLS Therapeutics Inc's total assets for Q4 2023 were $209.06M, a decrease of -2.87% from the previous quarter. DE:74D total liabilities were $111.36M for the fiscal quarter, a -1.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 209.06M$ 241.65M$ 275.90M$ 303.91M$ 319.67M
Total Liabilities
$ 111.36M$ 116.33M$ 115.17M$ 134.66M$ 141.47M
Total Equity Gross Minority
$ 97.70M$ 125.32M$ 160.74M$ 169.25M$ 178.20M
Total Capitalization
$ 97.70M$ 209.90M$ 244.87M$ 265.45M$ 264.78M
Preferred Stock Equity
Capital Lease Obligations
---$ 1.17M$ 903.00K
Currency in USD

HLS Therapeutics Inc Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis